HCV-IN-31

• UNSPSC Description:

  HCV-IN-31 (compound 4) is a HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon[1].

• Target Antigen:

  HCV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Field of Research:

  Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/hcv-in-31.html

• Smiles:

  OC[C@@H]1[C@@H](O)[C@](F)(C)[C@H](N2C3=NC(N)=NC(NC)=C3N=C2)O1

• Molecular Weight:

  312.30

• References & Citations:

  [1]Jean-Pierre Sommadossi, et al. BETA-D-2-DEOXY-2-ALPHA-FLUORO-2- BETA-C-SUBSTITUTED-2-MODIFIED N6-SUBSTITUTED PURINE NUCLEOTDES FORHCV TREATMENT. US20160257706A1.

• Shipping Conditions:

  Room Temperature

• CAS Number:

  1998705-62-6